AMERICAN BIO MEDICA CORPORATION: 10-Q filed 2017-11-14
What AMERICAN BIO MEDICA CORPORATION reported in its quarterly report filed 2017-11-14 (fiscal Q3 2017): 38 published measures, 96 facts as tagged in accession 0001144204-17-058768.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-11-14
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001144204-17-058768 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AMERICAN BIO MEDICA CORPORATION filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 3,143,000 | USD | |
| At 2016-12-31 | 3,371,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 2,287,000 | USD | |
| At 2016-12-31 | 2,346,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 856,000 | USD | |
| At 2016-12-31 | 1,025,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 150,000 | USD | |
| At 2016-12-31 | 156,000 | USD | |
| At 2016-09-30 | 221,000 | USD | |
| At 2015-12-31 | 158,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -49,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -252,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -88,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -130,000 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 158,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 185,000 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 44,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 0 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -100,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -116,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -64,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -6,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -20,552,000 | USD | |
| At 2016-12-31 | -20,300,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -2,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -1,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 1,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,000 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 810,000 | USD | |
| At 2016-12-31 | 824,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 33,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 49,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 5,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -83,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -60,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -118,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 2,182,000 | USD | |
| At 2016-12-31 | 2,386,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 70,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 204,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 71,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 210,000 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,517,000 | USD | |
| At 2016-12-31 | 1,593,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 306,000 | USD | |
| At 2016-12-31 | 304,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 107,000 | USD | |
| At 2016-12-31 | 93,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 521,000 | USD | |
| At 2016-12-31 | 556,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 561,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,779,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 671,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,069,000 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,462,000 | USD | |
| At 2016-12-31 | 1,582,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 566,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,696,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 611,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 1,951,000 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 26,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 94,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 28,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 136,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 29,297,333 | shares | |
| At 2016-12-31 | 28,842,788 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 21,115,000 | USD | |
| At 2016-12-31 | 21,037,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,437,000 | USD | |
| At 2016-12-31 | 1,467,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 21,000 | USD | |
| At 2016-12-31 | 21,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 22,000 | USD | |
| At 2016-12-31 | 0 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 49,000 | USD | |
| At 2016-12-31 | 92,000 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 376,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,154,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 368,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 1,106,000 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 64,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 69,000 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -56,000 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -170,000 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -27,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -10,000 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 110,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 119,000 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -1,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 2,000 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -32,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 49,000 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -116,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -127,000 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 2,000 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -38,000 | USD | 274 |
Inspect the source
- Entity
- AMERICAN BIO MEDICA CORPORATION / CIK 0000896747
- Captured
- SEC response SHA-256
8c81604293b852adeff68f1b8771cc4fa246b94a42c1d6f5b8af1757731f3992
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000896747.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))